These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma. Pignot G; Colin P; Zerbib M; Audenet F; Soulié M; Hurel S; Delage F; Irani J; Descazeaud A; Droupy S; Rozet F; Phé V; Ruffion A; Long JA; Crouzet S; Houlgatte A; Bigot P; Guy L; Faïs PO; Rouprêt M; Urol Oncol; 2014 Jan; 32(1):23.e1-8. PubMed ID: 23403206 [TBL] [Abstract][Full Text] [Related]
8. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. Ouzzane A; Colin P; Xylinas E; Pignot G; Ariane MM; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Bruyère F; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M; Eur Urol; 2011 Dec; 60(6):1258-65. PubMed ID: 21665356 [TBL] [Abstract][Full Text] [Related]
9. Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival. Colin P; Ouzzane A; Yates DR; Audenet F; Pignot G; Arvin-Berod A; Merigot de Treigny O; Laurent G; Valeri A; Irani J; Saint F; Gardic S; Gres P; Rozet F; Neuzillet Y; Ruffion A; Rouprêt M Ann Surg Oncol; 2012 Oct; 19(11):3613-20. PubMed ID: 22843187 [TBL] [Abstract][Full Text] [Related]
10. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma. Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349 [TBL] [Abstract][Full Text] [Related]
11. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. Kikuchi E; Horiguchi Y; Nakashima J; Hatakeyama N; Matsumoto M; Nishiyama T; Murai M J Urol; 2005 Dec; 174(6):2120-3; discussion 2124. PubMed ID: 16280740 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma. Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771 [TBL] [Abstract][Full Text] [Related]
13. Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit? Giannarini G; Kessler TM; Birkhäuser FD; Thalmann GN; Studer UE Eur Urol; 2011 Nov; 60(5):955-60. PubMed ID: 21807456 [TBL] [Abstract][Full Text] [Related]
14. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy. Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors influencing survival after nephroureterectomy for transitional cell carcinoma of the upper urinary tract. Kobayashi Y; Saika T; Manabe D; Nasu Y; Kumon H Acta Med Okayama; 2011 Apr; 65(2):143-9. PubMed ID: 21525971 [TBL] [Abstract][Full Text] [Related]
16. Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study. Vassilakopoulou M; de la Motte Rouge T; Colin P; Ouzzane A; Khayat D; Dimopoulos MA; Papadimitriou CA; Bamias A; Pignot G; Nouhaud FX; Hurel S; Guy L; Bigot P; Roumiguié M; Rouprêt M; Cancer; 2011 Dec; 117(24):5500-8. PubMed ID: 21638278 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract Collaboration. Fradet V; Mauermann J; Kassouf W; Rendon R; Jacobsen N; Fairey A; Izawa J; Kapoor A; Black P; Tanguay S; Chin J; So A; Lattouf JB; Bell D; Saad F; Sheyegan B; Drachenberg D; Cagiannos I; Lacombe L Urol Oncol; 2014 Aug; 32(6):839-45. PubMed ID: 24856978 [TBL] [Abstract][Full Text] [Related]
18. Does adequate bladder cuff excision impact outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma. Hou CP; Chang PL; Chen CL; Lin YH; Tsui KH Chang Gung Med J; 2011; 34(5):496-505. PubMed ID: 22035894 [TBL] [Abstract][Full Text] [Related]
19. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG; Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917 [TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Zigeuner R; Shariat SF; Margulis V; Karakiewicz PI; Roscigno M; Weizer A; Kikuchi E; Remzi M; Raman JD; Bolenz C; Bensalah K; Capitanio U; Koppie TM; Kassouf W; Sircar K; Patard JJ; Fernández MI; Wood CG; Montorsi F; Ströbel P; Wheat JC; Haitel A; Oya M; Guo CC; Ng C; Chade DC; Sagalowsky A; Langner C Eur Urol; 2010 Apr; 57(4):575-81. PubMed ID: 19959276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]